We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$181M
AUM Growth
+$14.5M
Cap. Flow
+$14.5M
Cap. Flow %
8%
Top 10 Hldgs %
46.73%
Holding
61
New
30
Increased
7
Reduced
10
Closed
12

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.19M
2
CI icon
Cigna
CI
+$6.79M
3
HUM icon
Humana
HUM
+$5.21M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$4.98M
5
HCA icon
HCA Healthcare
HCA
+$4.54M

Top Sells

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$15.9M
2
SNY icon
Sanofi
SNY
+$10.2M
3
BIIB icon
Biogen
BIIB
+$8.73M
4
VKTX icon
Viking Therapeutics
VKTX
+$6.62M
5
LLY icon
Eli Lilly
LLY
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 80.02%
2 Financials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRIS icon
51
Curis
CRIS
$9.71M
-417
Closed -$545K
HRTX icon
52
PUT
Heron Therapeutics
HRTX
$93.4M
-29,500
Closed -$814K
JNJ icon
53
PUT
Johnson & Johnson
JNJ
$640B
-20,000
Closed -$2.56M
LLY icon
54
Eli Lilly
LLY
$1.08T
-82,363
Closed -$6.37M
MRK icon
55
Merck
MRK
$322B
-120,369
Closed -$6.26M
OMCL icon
56
Omnicell
OMCL
$1.88B
-70,226
Closed -$3.05M
VTRS icon
57
Viatris
VTRS
$20.8B
-69,000
Closed -$2.71M
TBRG
58
DELISTED
TruBridge
TBRG
-113,860
Closed -$3.33M
IMGN
59
PUT
DELISTED
Immunogen Inc
IMGN
-274,800
Closed -$2.89M
EPZM
60
DELISTED
Epizyme, Inc
EPZM
-72,826
Closed -$1.29M
DERM
61
DELISTED
Dermira, Inc.
DERM
-190,300
Closed -$1.52M

Similar funds

Sio Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Sio Capital Management held 61 positions worth $181M, up 8.7% from $166M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sio Capital Management deployed $14.5M of net new capital in Q2 2018, opening 30 new positions and adding to 7 existing holdings. Its largest new stake was Cardinal Health: 126,770 shares worth $6.19M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 86% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Gyre Therapeutics, an estimated $15.9M trimmed.

  • Sio Capital Management's largest Q2 2018 buy was Cardinal Health: 126,770 shares worth $6.19M.
  • Sio Capital Management added most to HCA Healthcare in Q2 2018, an estimated $4.54M increase.
  • Sio Capital Management's biggest Q2 2018 reduction was Gyre Therapeutics, cutting an estimated $15.9M.
  • Sio Capital Management fully exited Biogen in Q2 2018, selling an estimated $8.73M.
  • Sio Capital Management's ten largest holdings make up 47% of its $181M portfolio in Q2 2018.
  • Sio Capital Management opened 30 new positions and closed 12 in Q2 2018.
  • Sio Capital Management's portfolio value rose 8.7% quarter-over-quarter to $181M.

Based on Sio Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.